-
1
-
-
79953881907
-
Statistical estimates of absenteeism attributable to seasonal and pandemic influenza from the Canadian Labour Force Survey
-
Schanzer DL, Zheng H, Gilmore J. Statistical estimates of absenteeism attributable to seasonal and pandemic influenza from the Canadian Labour Force Survey. BMC Infect Dis. 2011;11:90
-
(2011)
BMC Infect Dis
, vol.11
, pp. 90
-
-
Schanzer, D.L.1
Zheng, H.2
Gilmore, J.3
-
3
-
-
84942875583
-
Recommendations for prevention and control of influenza in children 2015-2016
-
Committee on Infectious Diseases, American Academy of Pediatrics
-
Committee on Infectious Diseases, American Academy of Pediatrics. Recommendations for prevention and control of influenza in children, 2015-2016. Pediatrics. 2015;136(4): 792-808
-
(2015)
Pediatrics
, vol.136
, Issue.4
, pp. 792-808
-
-
-
4
-
-
84898618697
-
Zanamivir for influenza in adults and children: Systematic review of clinical study reports and summary of regulatory comments
-
Heneghan CJ, Onakpoya I, Thompson M, Spencer EA, Jones M, Jefferson T. Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ. 2014;348:g2547
-
(2014)
BMJ
, vol.348
, pp. g2547
-
-
Heneghan, C.J.1
Onakpoya, I.2
Thompson, M.3
Spencer, E.A.4
Jones, M.5
Jefferson, T.6
-
5
-
-
85034092493
-
-
Revised 2016. Accessed August 1, 2016
-
GlaxoSmithKline. Relenza prescribing information. 2013. Revised 2016. Available at: https://www.gsksource. com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing-Information/Relenza/pdf/RELENZA-PI.pdf. Accessed August 1, 2016
-
(2013)
GlaxoSmithKline. Relenza Prescribing Information
-
-
-
6
-
-
77956116079
-
Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays
-
Nguyen HT, Sheu TG, Mishin VP, Klimov AI, Gubareva LV. Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays. Antimicrob Agents Chemother. 2010;54(9):3671-3677
-
(2010)
Antimicrob Agents Chemother
, vol.54
, Issue.9
, pp. 3671-3677
-
-
Nguyen, H.T.1
Sheu, T.G.2
Mishin, V.P.3
Klimov, A.I.4
Gubareva, L.V.5
-
7
-
-
84893290971
-
Safety and pharmacokinetics of intravenous zanamivir treatment in hospitalized adults with influenza: An open-label, multicenter, singlearm, phase II study
-
Marty FM, Man CY, van der Horst C, et al. Safety and pharmacokinetics of intravenous zanamivir treatment in hospitalized adults with influenza: An open-label, multicenter, singlearm, phase II study. J Infect Dis. 2014;209(4):542-550
-
(2014)
J Infect Dis
, vol.209
, Issue.4
, pp. 542-550
-
-
Marty, F.M.1
Man, C.Y.2
Van Der Horst, C.3
-
8
-
-
85009420566
-
Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: An international, randomised, double-blind, doubledummy, phase 3 trial
-
Marty FM, Vidal-Puigserver J, Clark C, et al. Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: An international, randomised, double-blind, doubledummy, phase 3 trial. Lancet Respir Med. 2017;5(2):135-146
-
(2017)
Lancet Respir Med
, vol.5
, Issue.2
, pp. 135-146
-
-
Marty, F.M.1
Vidal-Puigserver, J.2
Clark, C.3
-
9
-
-
85034042749
-
-
NIAID. Division of AIDS (DAIDS) table for grading the severity of adult and pediatric adverse events. Accessed August 1, 2016
-
NIAID. Division of AIDS (DAIDS) table for grading the severity of adult and pediatric adverse events. 2014. Available at: http://rsc.Tech-res. com/docs/default-source/safety/daids-Ae-grading-Table-v2-nov2014.pdf. Accessed August 1, 2016
-
(2014)
-
-
-
10
-
-
79851471047
-
Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors
-
Pizzorno A, Bouhy X, Abed Y, Boivin G. Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors. J Infect Dis. 2011;203(1):25-31
-
(2011)
J Infect Dis
, vol.203
, Issue.1
, pp. 25-31
-
-
Pizzorno, A.1
Bouhy, X.2
Abed, Y.3
Boivin, G.4
-
11
-
-
79955546685
-
Neuraminidase inhibitor sensitivity and receptor-binding specificity of Cambodian clade 1 highly pathogenic H5N1 influenza virus
-
Naughtin M, Dyason JC, Mardy S, Sorn S, von Itzstein M, Buchy P. Neuraminidase inhibitor sensitivity and receptor-binding specificity of Cambodian clade 1 highly pathogenic H5N1 influenza virus. Antimicrob Agents Chemother. 2011;55(5):2004-2010
-
(2011)
Antimicrob Agents Chemother
, vol.55
, Issue.5
, pp. 2004-2010
-
-
Naughtin, M.1
Dyason, J.C.2
Mardy, S.3
Sorn, S.4
Von Itzstein, M.5
Buchy, P.6
-
12
-
-
85034026071
-
-
WHO. Summary of neuraminidase amino acid substitutions associated with reduced inhibition by neuraminidase inhibitors (NAI) Accessed February, 1, 2017
-
WHO. Summary of neuraminidase amino acid substitutions associated with reduced inhibition by neuraminidase inhibitors (NAI). 2016. Available at: www.who. int/influenza/gisrs-laboratory/antiviral-susceptibility/avwg2014-nai-substitution-Table.pdf. Accessed February 1, 2017
-
(2016)
-
-
-
13
-
-
38949197905
-
Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario Canada
-
Toronto Invasive Bacterial Diseases Network
-
McGeer A, Green KA, Plevneshi A, et al; Toronto Invasive Bacterial Diseases Network. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis. 2007;45(12): 1568-1575
-
(2007)
Clin Infect Dis
, vol.45
, Issue.12
, pp. 1568-1575
-
-
McGeer, A.1
Green, K.A.2
Plevneshi, A.3
-
14
-
-
84987920191
-
Phenotypic and genotypic analysis of influenza viruses isolated from adult subjects during a phase II study of intravenous zanamivir in hospitalised subjects
-
Yates PJ, Raimonde DS, Zhao HH, et al. Phenotypic and genotypic analysis of influenza viruses isolated from adult subjects during a phase II study of intravenous zanamivir in hospitalised subjects. Antiviral Res. 2016;134:144-152
-
(2016)
Antiviral Res
, vol.134
, pp. 144-152
-
-
Yates, P.J.1
Raimonde, D.S.2
Zhao, H.H.3
-
15
-
-
85034022209
-
-
Centers for Disease Control and Prevention. Flu vaccination coverage, United States 2013-14 influenza season. Accessed November 1, 2016
-
Centers for Disease Control and Prevention. Flu vaccination coverage, United States, 2013-14 influenza season. 2014. Available at: www.cdc. gov/flu/pdf/fluvaxview/vax-coverage-1314estimates.pdf. Accessed November 1, 2016
-
(2014)
-
-
-
16
-
-
48949089658
-
-
Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) 2008
-
Fiore AE, Shay DK, Broder K, et al; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep. 2008;57(RR-7):1-60
-
(2008)
MMWR Recomm Rep
, vol.57
, Issue.7
, pp. 1-60
-
-
Fiore, A.E.1
Shay, D.K.2
Broder, K.3
|